CERAMENT® | BONE VOID FILLER, formerly sold in the U.S. through Zimmer Biomet, is now exclusively sold directly from BONESUPPORT, the developer and sole manufacturer of CERAMENT.
Below are important facts about the distribution transition and how to avoid a disruption in CERAMENT supply.
U.S. Customer Service:
BONESUPPORT is a Scandinavian orthobiologics company that develops, manufactures and markets CERAMENT®, an innovative platform portfolio of radiopaque, injectable and drug-eluting bone void fillers that have a proven ability to heal defects by remodeling to host bone in six to twelve months.
Our products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.
BONESUPPORT’s U.S. organization is located in Boston, MA. Our U.S. team is committed to offering the highest level of service and support and minimizing disruption of supply to current CERAMENT BONE VOID FILLER customers.
The CERAMENT BONE VOID FILLER product that we distribute directly is the same product that has been available in the U.S. since FDA clearance in 2008.
Zimmer Biomet can no longer sell or provide surgery support for CERAMENT. Customers should update their systems to reflect the new CERAMENT product codes and contact BONESUPPORT to place a direct orde
Zimmer Biomet can no longer sell or provide surgery support for CERAMENT. Customers should contact BONESUPPORT to place a direct order.
BONESUPPORT recommends you make the change now in order to avoid disruption of supply to CERAMENT.
BONESUPPORT has its own unique product codes for CERAMENT. Zimmer Biomet codes are now expired. Please update your system to reflect the BONESUPPORT codes.